June 14, 2018
Sanofi and Recipharm announce transfer of Holmes Chapel Manufacturing site
Recipharm and Sanofi announced today that they have signed an agreement to transfer the Holmes Chapel site from global healthcare…
Pharmaceuticals, Biotechnology and Life Sciences
Author: Dino Mustafić
June 13, 2018
TiGenix’s CEO leaves as operations integrate into Takeda
TiGenix NV’s Chief Executive Officer, Eduardo Bravo will depart the board of directors and his role as CEO of TiGenix…
June 13, 2018
4D cleared to study Blautix, its Irritable Bowel Syndrome treatment in UK and Ireland
4D pharma has been cleared by the Medicines and Healthcare Products Regulatory Agency (MHRA) and the Health Products Regulatory Authority…
June 13, 2018
Santhera Pharmaceuticals submits NDA in South Korea for Raxone for the treatment of LHON
Santhera Pharmaceuticals said on Tuesday that the Korean Ministry of Food and Drug Safety (MFDS) has accepted its new drug…
June 13, 2018
Keytruda becomes first anti-PD-1 therapy for patients with advanced cervical cancer
The US Food and Drug Administration approved Merck’s Keytruda (pembrolizumab) for patients with recurrent or metastatic cervical cancer with disease…
June 12, 2018
Alvogen, Pfenex in a US marketed osteoporosis drug commercialization deal
Alvogen and Pfenex have signed a deal which grants Alvogen exclusive rights to commercialize Pfenex’s lead drug candidate, PF708, a…
June 12, 2018
FDA grants Fast Track designation in the US for Nordic Nanovector’s Follicular Lymphoma drug
The US Food & Drug Administration (FDA) has granted Fast Track designation to Nordic Nanovector’s Betalutin (177Lu-lilotomab satetraxetan) for the treatment of…
June 12, 2018
AstraZeneca and Eli Lilly quit Phase III clinical trials for Alzheimer’s disease drug
AstraZeneca and Eli Lilly are abandoning the global Phase III clinical trials of lanabecestat, an oral beta secretase cleaving enzyme…
June 7, 2018
Bayer closes Monsanto acquisition
Bayer successfully completed the acquisition of Monsanto on Thursday. Shares in the U.S. company will no longer be traded on the…
June 7, 2018
BioMarin bags $20 million in milestone payments
BioMarin Pharmaceutical has received $20 million in milestone payments from Pfizer Inc, it said Thursday.